FDA wants feedback on how to regulate generative AI in medicine

The FDA is seeking public feedback to shape its regulatory approach for generative AI in medical devices, focusing on risk assessment, market evaluation, and ongoing safety monitoring to ensure patient safety while enabling innovation.

This Wire brief sits within Fusion42's coverage of Digital Health, and 19 sources have reported it between 18 Aug 2026 and 18 Sep 2026.